Drug maker Alumis (ALMS) is climbing 7% after investment bank Oppenheimer started coverage of the name with an Outperform ...
Fintel reports that on January 30, 2025, Oppenheimer initiated coverage of Alumis (NasdaqGS:ALMS) with a Outperform ...
Oppenheimer assumed coverage on shares of Alumis (NASDAQ:ALMS – Free Report) in a research note published on Thursday morning, MarketBeat.com reports. The firm issued an outperform rating and a $32.00 ...
Peace prospects look bleak in Myanmar as a civil war rages despite international pressure on the military four years after it ...
Oppenheimer launched its coverage of Alumis (NASDAQ:ALMS) with an Outperform recommendation and a 12–18-month price target of ...
Type a few symbols and Take a Trial. The signals for these will appear immediately on your My Stocks Page; add more too.
Oppenheimer initiated coverage of Alumis (ALMS) with an Outperform rating and $32 price target The company is focused on delivering ...
There’s a lot to be optimistic about in the Materials sector as 2 analysts just weighed in on Alumis Inc. (ALMS – Research Report) and Corning ...